UK markets closed

Newron Pharmaceuticals S.p.A. (NWRN.SW)

Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
9.10+0.79 (+9.51%)
At close: 05:30PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
5,921
9,057
6,094
5,762
5,258
Cost of revenue
-
-
-
-
295
Gross profit
-
-
-
-
4,963
Operating expenses
Research development
9,266
13,152
12,005
10,725
14,853
Selling general and administrative
3,647
4,062
3,617
3,531
4,043
Total operating expenses
16,843
20,686
19,396
18,119
23,324
Operating income or loss
-10,922
-11,629
-13,302
-12,357
-18,066
Interest expense
3,518
4,168
3,947
2,918
2,239
Income before tax
-14,457
-16,200
-17,472
-14,884
-19,618
Income tax expense
17
24
21
17
1,380
Income from continuing operations
-14,474
-16,224
-17,493
-14,901
-20,998
Net income
-14,474
-16,224
-17,493
-14,901
-20,998
Net income available to common shareholders
-14,474
-16,224
-17,493
-14,901
-20,998
Basic EPS
-0.89
-0.91
-0.98
-0.84
-1.18
Diluted EPS
-0.89
-0.91
-0.98
-0.84
-1.18
Basic average shares
17,845
17,845
17,845
17,845
17,845
Diluted average shares
17,845
17,845
17,845
17,845
17,845